First Command Advisory Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.46K Hold
100
﹤0.01% 837
2026
Q1
$5.23K Hold
100
﹤0.01% 744
2025
Q4
$5.12K Hold
100
﹤0.01% 528
2025
Q3
$3.89K Hold
100
﹤0.01% 489
2025
Q2
$3.01K Hold
100
﹤0.01% 463
2025
Q1
$2.85K Hold
100
﹤0.01% 440
2024
Q4
$3.3K Hold
100
﹤0.01% 410
2024
Q3
$3.73K Hold
100
﹤0.01% 406
2024
Q2
$3.36K Buy
+100
New +$3.35K ﹤0.01% 417
2024
Q1
Sell
-100
Closed -$3.29K 653
2023
Q4
$3.29K Hold
100
﹤0.01% 408
2023
Q3
$2.72K Buy
+100
New +$3.01K ﹤0.01% 394

Other funds holding SBIO

First Command Advisory Services's SBIO Position: Q2 2026 in Review

First Command Advisory Services held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2026 at 100 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #837.

First Command Advisory Services first reported a position in SBIO in Q3 2023 and has held it in 11 quarters since. 38 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • First Command Advisory Services held 100 shares of ALPS Medical Breakthroughs ETF worth $6.46K as of Q2 2026.
  • First Command Advisory Services left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2026.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #837 holding.
  • First Command Advisory Services first reported a position in ALPS Medical Breakthroughs ETF in Q3 2023 and has held it in 11 quarters since.
  • 38 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.